LEMTRADA (alemtuzumab): Reviews and patient testimonials
Medication indications
LEMTRADA 12 mg concentrate for solution for infusion
LEMTRADA is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features (see sections 4.4 and 5.1).
Route of administration: Injectable
Molecule: alemtuzumab
Patients' opinions on LEMTRADA
In brief
General satisfaction level: 10.00/10 Learn more
Treatment's effectiveness: 10.00/10 Learn more
Ease of use: 10.00/10 Learn more
Adherence to prescription: 1.00/10 Learn more
Detected side effects: 3.00/10 Learn more
Improvement in the quality of life: 7.00/10 Learn more
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community